ADMA Biologics, Inc. (ADMA)
8.23
-0.23
(-2.72%)
USD |
NASDAQ |
May 22, 12:49
ADMA Biologics EPS Diluted (Quarterly) : 0.1889 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| AnaptysBio, Inc. | -1.843 |
| Kodiak Sciences, Inc. | -0.9402 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 45.33M |
| Revenue (Quarterly) | 114.49M |
| Total Expenses (Quarterly) | 69.16M |
| Enterprise Value | 2.027B |
| Gross Profit Margin (Quarterly) | 70.48% |
| Profit Margin (Quarterly) | 39.59% |
| Earnings Yield | 8.24% |
| Operating Earnings Yield | 10.29% |
| Normalized Earnings Yield | 8.352 |